Jazz Pharmaceuticals plc
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership6,729 shares
Latest Disclosed Value $ 1,271,869
Captrust Financial Advisors reports 34.55% increase in ownership of JAZZ / Jazz Pharmaceuticals plc

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 6,729 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $1,272,117 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 5,001 shares of Jazz Pharmaceuticals plc. This represents a change in shares of 34.55% during the quarter. The current value of the position is $1,615,364 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 6,729 1,728 34.55 1,272 49.53 0.0022
2026-02-17 2025-12-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 5,001 324 6.93 850 37.99 0.0016
2025-11-19 2025-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,677 62 1.34 616 25.97 0.0013
2025-08-15 2025-06-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,615 -255 -5.24 490 -19.04 0.0011
2025-05-15 2025-03-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,870 -467 -8.75 605 -8.07 0.0015
2025-02-14 2024-12-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 5,337 372 7.49 657 18.81 0.0019
2024-11-14 2024-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,965 430 9.48 553 14.26 0.0016
2024-08-15 2024-06-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,535 -258 -5.38 484 -16.12 0.0016
2024-05-15 2024-03-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,793 -522 -9.82 577 -11.64 0.0021
2024-02-14 2023-12-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 5,315 -158 -2.89 654 -7.77 0.0023
2023-11-15 2023-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 5,473 -7,281 -57.09 708 -55.22 0.0027
2023-08-15 2023-06-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 12,754 7,825 158.75 1,581 119.28 0.0062
2023-05-15 2023-03-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,929 179 3.77 721 -4.63 0.0032
2023-02-15 2022-12-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,750 -156 -3.18 757 15.60 0.0038
2022-11-16 2022-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Stock G50871105 4,906 1,180 31.67 654 12.56 0.0038
2022-08-23 2022-06-30 13F/A-1 JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 3,726 19 0.51 581 0.69 0.0037
2022-08-16 2022-06-30 13F JAZZ PHARMACEUTICALS PLC SHS USD COM G50871105 4,898 1,191 764 0.0055
2022-05-16 2022-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 3,707 86 2.38 577 25.16 0.0037
2022-02-14 2021-12-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 3,621 240 7.10 461 4.77 0.0032
2021-11-16 2021-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 3,381 -107 -3.07 440 -29.03 0.0037
2021-08-16 2021-06-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 3,488 250 7.72 620 16.54 0.0058
2021-05-17 2021-03-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 3,238 418 14.82 532 14.41 0.0058
2021-02-16 2020-12-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 2,820 110 4.06 465 18.93 0.0062
2020-11-17 2020-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 2,710 0 0.00 391 31.65 0.0065
2020-08-14 2020-06-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 2,710 -605 -18.25 297 -6.31 0.0049
2020-05-15 2020-03-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 3,315 -525 -13.67 317 -44.39 0.0070
2020-02-14 2019-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 3,840 3,620 1,645.45 570 1,935.71 0.0090
2019-11-14 2019-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 220 0 0.00 28 -9.68 0.0010
2019-08-13 2019-06-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 220 120 120.00 31 121.43 0.0011
2019-05-15 2019-03-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 100 -14 -12.28 14 0.00 0.0006
2019-02-13 2018-12-31 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 114 14 14.00 14 -17.65 0.0008
2018-11-15 2018-09-30 13F JAZZ PHARMACEUTICALS PLC SHS USD Common Stock G50871105 100 100 17 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.